Clinical Trial Update: Tocilizumab in Patients With Schnitzler's Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tocilizumab in Schnitzler's Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schnitzler Syndrome

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Karoline Krause | Conditions: Schnitzler's Syndrome | Phase 2 | Status: COMPLETED